{
    "xml": "<topic id=\"PHP3486\" outputclass=\"drug\" rev=\"1.17\" type=\"drug\" namespace=\"/drugs/amikacin\" basename=\"amikacin\" title=\"AMIKACIN\">\n<title>AMIKACIN</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_129\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/aminoglycosides/amikacin\">Amikacin</xref>\n</p>\n<data name=\"vtmid\">48836000</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_296174173\" title=\"Aminoglycosides\">Aminoglycosides</xref>\n</data>\n<data name=\"inheritsFromClass\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34544\" title=\"AMINOGLYCOSIDES\" namespace=\"/drug-classes/aminoglycosides\">AMINOGLYCOSIDES</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP67300\" outputclass=\"indicationsAndDose\" rev=\"1.36\" parent=\"/drugs/amikacin\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Serious Gram-negative infections resistant to gentamicin (multiple daily dose regimen)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intramuscular injection or by slow intravenous injection or by intravenous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>15&#8239;mg/kg daily in 2 divided doses, increased to 22.5&#8239;mg/kg daily in 3 divided doses for up to 10 days, higher dose to be used in severe infections; maximum 1.5&#8239;g per day; maximum 15&#8239;g per course.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Serious Gram-negative infections resistant to gentamicin (once daily dose regimen)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intravenous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 15&#8239;mg/kg (max. per dose 1.5&#8239;g once daily), dose to be adjusted according to serum-amikacin concentration; maximum 15&#8239;g per course.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"extremesOfBodyWeight\">\n<title>Doses at extremes of body-weight</title>\n<p>To avoid excessive dosage in obese patients, use ideal weight for height to calculate dose and monitor serum-amikacin concentration closely</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP67195\" outputclass=\"sideEffects\" rev=\"1.10\" parent=\"/drugs/amikacin\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"uncommon\">\n<p outputclass=\"title\">Uncommon</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Rash</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP67122\" outputclass=\"monitoringRequirements\" parent=\"/drugs/amikacin\">\n<title>Monitoring requirements</title>\n<body>\n<section outputclass=\"therapeuticDrugMonitoring\">\n<sectiondiv>\n<p>\n<i>Multiple daily dose regimen</i>: one-hour (&#8216;peak&#8217;) serum concentration should not exceed 30&#8239;mg/litre; pre-dose (&#8216;trough&#8217;) concentration should be less than 10&#8239;mg/litre.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use</p>\n<p>\n<i>Once daily dose regimen</i>: pre-dose (&#8216;trough&#8217;) concentration should be less than 5&#8239;mg/litre.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP67413\" outputclass=\"directionsForAdministration\" rev=\"1.14\" parent=\"/drugs/amikacin\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use</p>\n<p>For <i>intravenous infusion</i> (<i>Amikin</i>\n<sup>\n<tm tmtype=\"reg\"/>\n</sup>); intermittent in Glucose 5% <i>or</i> Sodium chloride 0.9%. To be given over 30 minutes.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP58277\" outputclass=\"prescribingAndDispensingInformation\" rev=\"1.20\" parent=\"/drugs/amikacin\">\n<title>Prescribing and dispensing information</title>\n<body>\n<section>\n<sectiondiv>\n<p>Once daily dose regime not to be used for endocarditis, febrile neutropenia, or meningitis. Consult local guidelines.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP3486-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/amikacin\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75769\" title=\"Solution for injection\" namespace=\"/drugs/amikacin/solution-for-injection\">Solution for injection</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78330\" namespace=\"/treatment-summaries/tuberculosis\" title=\"Tuberculosis\" count=\"1\" rel=\"backlink\">Tuberculosis</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78593\" namespace=\"/treatment-summaries/aminoglycosides\" title=\"Aminoglycosides\" count=\"4\" rel=\"backlink\">Aminoglycosides</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_129\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/aminoglycosides/amikacin\" title=\"Amikacin\" count=\"1\" rel=\"link\">Amikacin</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34544\" namespace=\"/drug-classes/aminoglycosides\" title=\"AMINOGLYCOSIDES\" count=\"1\" rel=\"link\">AMINOGLYCOSIDES</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75769\" namespace=\"/drugs/amikacin/solution-for-injection\" title=\"Solution for injection\" count=\"1\" rel=\"link\">Solution for injection</xref>\n</links>\n</topic>",
    "id": "PHP3486",
    "outputclass": "drug",
    "rev": "1.17",
    "type": "drug",
    "namespace": "/drugs/amikacin",
    "basename": "amikacin",
    "title": "AMIKACIN",
    "interactants": [
        {
            "id": "bnf_int_129",
            "label": "Amikacin"
        }
    ],
    "vtmid": "48836000",
    "drugClassification": [
        "Aminoglycosides"
    ],
    "inheritsFromClass": [
        "AMINOGLYCOSIDES"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Serious Gram-negative infections resistant to gentamicin (multiple daily dose regimen)",
                        "html": "Serious Gram-negative infections resistant to gentamicin (multiple daily dose regimen)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intramuscular injection or slow intravenous injection or intravenous infusion"
                    ],
                    "textContent": "By intramuscular injection or by slow intravenous injection or by intravenous infusion",
                    "html": "By intramuscular injection or by slow intravenous injection or by intravenous infusion"
                },
                "adult": [
                    {
                        "textContent": "15 mg/kg daily in 2 divided doses, increased to 22.5 mg/kg daily in 3 divided doses for up to 10 days, higher dose to be used in severe infections; maximum 1.5 g per day; maximum 15 g per course.",
                        "html": "<p>15&#8239;mg/kg daily in 2 divided doses, increased to 22.5&#8239;mg/kg daily in 3 divided doses for up to 10 days, higher dose to be used in severe infections; maximum 1.5&#8239;g per day; maximum 15&#8239;g per course.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Serious Gram-negative infections resistant to gentamicin (once daily dose regimen)",
                        "html": "Serious Gram-negative infections resistant to gentamicin (once daily dose regimen)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous infusion"
                    ],
                    "textContent": "By intravenous infusion",
                    "html": "By intravenous infusion"
                },
                "adult": [
                    {
                        "textContent": "Initially 15 mg/kg (max. per dose 1.5 g once daily), dose to be adjusted according to serum-amikacin concentration; maximum 15 g per course.",
                        "html": "<p>Initially 15&#8239;mg/kg (max. per dose 1.5&#8239;g once daily), dose to be adjusted according to serum-amikacin concentration; maximum 15&#8239;g per course.</p>"
                    }
                ]
            }
        ],
        "extremesOfBodyWeight": [
            {
                "type": "extremesOfBodyWeight",
                "title": "Doses at extremes of body-weight",
                "textContent": "To avoid excessive dosage in obese patients, use ideal weight for height to calculate dose and monitor serum-amikacin concentration closely",
                "html": "<p>To avoid excessive dosage in obese patients, use ideal weight for height to calculate dose and monitor serum-amikacin concentration closely</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "uncommon": [
                    {
                        "type": "uncommon",
                        "textContent": "Rash",
                        "html": "Rash",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    }
                ]
            }
        }
    },
    "monitoringRequirements": {
        "therapeuticDrugMonitoring": [
            {
                "type": "therapeuticDrugMonitoring",
                "textContent": "Multiple daily dose regimen: one-hour (&#8216;peak&#8217;) serum concentration should not exceed 30 mg/litre; pre-dose (&#8216;trough&#8217;) concentration should be less than 10 mg/litre.",
                "html": "<p>\n<i>Multiple daily dose regimen</i>: one-hour (&#8216;peak&#8217;) serum concentration should not exceed 30&#8239;mg/litre; pre-dose (&#8216;trough&#8217;) concentration should be less than 10&#8239;mg/litre.</p>"
            },
            {
                "type": "therapeuticDrugMonitoring",
                "specificity": {
                    "textContent": "With intravenous use",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "Once daily dose regimen: pre-dose (&#8216;trough&#8217;) concentration should be less than 5 mg/litre.",
                "html": "<p>\n<i>Once daily dose regimen</i>: pre-dose (&#8216;trough&#8217;) concentration should be less than 5&#8239;mg/litre.</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With intravenous use",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "For intravenous infusion (Amikin ); intermittent in Glucose 5% or Sodium chloride 0.9%. To be given over 30 minutes.",
                "html": "<p>For <i>intravenous infusion</i> (<i>Amikin</i>\n<sup>\n<tm tmtype=\"reg\"/>\n</sup>); intermittent in Glucose 5% <i>or</i> Sodium chloride 0.9%. To be given over 30 minutes.</p>"
            }
        ]
    },
    "prescribingAndDispensingInformation": {
        "prescribingAndDispensingInformation": [
            {
                "type": "prescribingAndDispensingInformation",
                "textContent": "Once daily dose regime not to be used for endocarditis, febrile neutropenia, or meningitis. Consult local guidelines.",
                "html": "<p>Once daily dose regime not to be used for endocarditis, febrile neutropenia, or meningitis. Consult local guidelines.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP75769",
                "label": "Solution for injection",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78330",
                "label": "Tuberculosis",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78593",
                "label": "Aminoglycosides",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_129",
                "label": "Amikacin",
                "type": "interaction"
            }
        ],
        "drugClass": [
            {
                "id": "PHP34544",
                "label": "AMINOGLYCOSIDES",
                "type": "drugClass"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP75769",
                "label": "Solution for injection",
                "type": "medicinalForm"
            }
        ]
    }
}